NASDAQ : SPRC
SciSparc Ltd. — Key statistics
Healthcare · Biotechnology · Israel
Last price 0.6763 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 392.91K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 392,912 |
| Enterprise Value | -1.36M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 580,973 |
| Shares Outstanding | 580,973 |
| Shares Change (YoY) | +580.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 9.27% |
| Float | 561,123 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | n/a |
| PB Ratio | 0.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.87 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.46 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -164.49% |
| Return on Assets (ROA) | -26.05% |
| Return on Invested Capital (ROIC) | -51.76% |
| Return on Capital Employed (ROCE) | -40.61% |
| Weighted Average Cost of Capital (WACC) | 17.30% |
| Revenue Per Employee | $226,333 |
| Profits Per Employee | -$2.74M |
| Employee Count | 3 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.55 |
| 52-Week Price Change | -97.79% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 5.59 |
| Relative Strength Index (RSI) | 16.83 |
| Average Volume (20 Days) | 4,196,160 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 12,131 |
| Short Previous Month | 11,375 |
| Short % of Shares Out | 2.09% |
| Short % of Float | 2.16% |
| Short Ratio (days to cover) | 0.01 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 679,000 |
| Gross Profit | 6.46M |
| Operating Income | -4.92M |
| Pretax Income | -9.20M |
| Net Income | -8.22M |
| EBITDA | -4.83M |
| EBIT | -4.92M |
| Loss Per Share | -$22.11 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.44M |
| Total Debt | 2.68M |
| Net Cash | 1.76M |
| Net Cash Per Share | $3.02 |
| Equity (Book Value) | 11.27M |
| Book Value Per Share | 6.79 |
| Working Capital | -808,000 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.84M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 96,000 |
| Net Borrowing | 2.22M |
| Free Cash Flow | -5.84M |
| FCF Per Share | -$10.05 |
Margins
| Measure | Value |
|---|
| Gross Margin | 950.81% |
| Operating Margin | -725.18% |
| Pretax Margin | -1,355.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -580.60% |
| Shareholder Yield | -580.60% |
| Earnings Yield | -3,269.27% |
| FCF Yield | -1,485.57% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 478.16% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 4, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.56 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |